Collaboration expands research of new delivery platform beyond liver tissues, supporting potential preclinical development and strengthening Singapore’s position as a biomedical innovation hub...
The single-cell and AI-powered solution helping to enhance precision oncology solutions...
Major new investments bolster CEPI’s five-year plan to develop vaccines against high-risk pathogens and strengthen global preparedness for epidemic and pandemic threats....
The evaluation, completed in March 2026, encompassed a full walkthrough of all four disease modules, clinical workflow integration assessment, usability analysis using the Nielsen heuristic framework...
The new facility expands access to fertility assessment, IVF-related services, embryology and laboratory capabilities for couples in Singapore. ...
The research emphasizes that analyzing specific EIS features provides a significantly more sensitive assessment of age-related barrier changes than standard summarized values...
Lancet-published Integral-1 results support nacubactam’s potential as a new option against drug-resistant Gram-negative infections ...
The collaboration helps raise awareness of personal osteoporosis risk earlier and encourages proactive steps before fractures occur...
The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...
New robotic microtomy solution targets efficiency and scalability in laboratory tissue processing...
